Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae Causing Bacteremia from India—A First Report

Colistin has long been a reserve drug used for the treatment of carbapenem resistant Klebsiella pneumoniae. Carbapenem resistance in K. pneumoniae has been increasing and is as high as 44% in India. Although a reserve agent, with rise in rates of resistance to carbapenems, the usage of colistin has...

Descripción completa

Detalles Bibliográficos
Autores principales: Pragasam, Agila K., Shankar, Chaitra, Veeraraghavan, Balaji, Biswas, Indranil, Nabarro, Laura E. B., Inbanathan, Francis Y., George, Biju, Verghese, Santhosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220082/
https://www.ncbi.nlm.nih.gov/pubmed/28119670
http://dx.doi.org/10.3389/fmicb.2016.02135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220082/
https://www.ncbi.nlm.nih.gov/pubmed/28119670
http://dx.doi.org/10.3389/fmicb.2016.02135

Ejemplares similares